The researchers found that, compared to the AGHE, the Mediterranean diet resulted in a significant decrease in waist ...

Eli Lilly plans to launch its experimental oral weight-loss drug orforglipron in India, a senior executive said on Thursday, ...

A new analysis found that semaglutide and tirzepatide offer great health benefits over a lifetime, but the immense scale of ...

Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar ...

The deal returns the drug-maker to the growing market for obesity drugs after scrapping an experimental weight-loss pill.

Though the trial for patients with obesity and type 2 diabetes will come to an end, an obesity-only trial will continue.

If you’re considering using medication to reach a healthy body weight, your first question might be: Are weight loss drugs ...

Eli Lilly (NYSE:LLY) has decided to stop one of its obesity drug combination trials, pressing pause on a study that paired ...

New York City doctors reveals how weight-loss drugs reduce inflammatory cytokines by decreasing fat cells, potentially preventing cancer and autoimmune diseases.

Excellus BlueCross BlueShield is pushing back against reports that it will no longer cover GLP-1 medications, saying drugs ...

“Semaglutide hits one receptor. It was the first one that came out,” Dr. Howe said. “Tirzepatide hits two receptors, and studies show that with tirzepatide, you get about a 32% weight loss compared to ...

Some women are experiencing significant hair loss as a side effect of testosterone therapy and popular weight-loss drugs. Rapid weight loss from GLP-1 medications like Ozempic and Zepbound can trigger ...